News from samsung biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 28, 2023, 06:00 ET Samsung Biologics engages suppliers to advance global decarbonization targets

Samsung Biologics (KRX: 207940.KS), a global contract and development and manufacturing organization (CDMO), today hosted its inaugural Supplier ESG...

Oct 25, 2023, 02:51 ET Samsung Biologics reports third quarter 2023 financial results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), today announced financial results ...

Oct 23, 2023, 09:00 ET Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma's portfolio companies

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture...

Sep 17, 2023, 19:57 ET Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol...

Aug 23, 2023, 19:59 ET Samsung Biologics appoints new leadership to oversee quality and regulatory affairs

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced the appointments of Gail...

Jul 26, 2023, 03:23 ET Samsung Biologics Reports Second Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), today announced financial results ...

Jul 18, 2023, 07:00 ET Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social...

Jun 06, 2023, 07:00 ET Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

While attending the 2023 BIO International Convention, Samsung Biologics (KRX:207940.KS), a leading contract development and manufacturing...

Apr 24, 2023, 02:51 ET Samsung Biologics Reports First Quarter 2023 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), today announced financial results ...

Mar 17, 2023, 07:00 ET Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will...

Jan 27, 2023, 01:52 ET Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Jan 10, 2023, 19:01 ET Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future

Samsung Biologics is one of 19 companies to have been awarded the 2022 Terra Carta Seal. The Terra Carta Seal recognises global companies which are...

Oct 26, 2022, 19:35 ET Samsung Biologics Reports Third Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization, released today its fiscal year 2022 third-quarter...

Oct 13, 2022, 07:00 ET Samsung Biologics obtains three global ISO certifications

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today it has successfully renewed ...

Oct 11, 2022, 07:00 ET Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that its Plant 4 – the...

Sep 29, 2022, 07:00 ET Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022

Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary...

Sep 28, 2022, 07:00 ET Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), was awarded the Gold Sustainability Rating...

Aug 01, 2022, 09:00 ET GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab...

Jul 27, 2022, 02:43 ET Samsung Biologics Reports Second Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Jul 18, 2022, 07:00 ET Samsung Biologics to purchase land for its second Bio Campus

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has signed a...

Jul 11, 2022, 07:00 ET 'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today published its second annual ESG...

Apr 27, 2022, 02:42 ET Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results ...

Apr 20, 2022, 02:45 ET Samsung Biologics completes full acquisition of Samsung Bioepis

Samsung Biologics (KRX: 207940.KS) announced today that it has completed the purchase of Biogen's stake in the Samsung Bioepis joint venture for USD...

Mar 28, 2022, 21:42 ET Samsung Biologics holds 11th Annual General Meeting of Shareholders

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), hosted its 11th Annual General...

Feb 07, 2022, 07:00 ET Samsung Biologics receives 2022 CMO Leadership Award in all six categories

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has been...